News | June 23, 2015

Extensive survey finds most users value ease of use and functionality, prefer bundling systems

ECRI Institute, linear accelerators, linac, purchase, survey

June 23, 2015 - The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac) for external beam radiation therapy. The report is a compilation of results from a survey of hundreds of users of linac-based radiosurgery systems; participants were asked to rate the functions and features of the four major linac vendors: Accuray, Brainlab, Elekta and Varian Medical Systems.

Among the factors considered were:

  • Ease of use;
  • Functionality;
  • Reliability;
  • Siting requirements;
  • Implementation;
  • Service;
  • Vendor support;
  • Training; and
  • Cost

 

According to the survey results, the linac models with the highest overall ratings scored the highest for ease of use, functionality, imaging capabilities and device interoperability.

ECRI also sought to determine the different ways that linacs are employed. The survey found that nearly half of all respondents typically utilize their linac for both standard radiotherapy and stereotactic radiosurgery.

Fifty-nine percent of those surveyed use a treatment planning system and linac from the same manufacturer, and 47 percent use an oncology information system that is also sold by the linac manufacturer. This bundling of systems and services has been a growing trend in the marketplace over the past few years, offering benefits such as higher equipment discounts, reduced training expenses and coinciding service contracts.

The ECRI Institute is an independent nonprofit organization that conducts research into the most effective approaches for improving patient care.  

For more information: www.ecri.org


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now